ARID1A and colorectal carcinoma: We further explored the mechanism by which ARID1A loss and c-MET inhibition synergistically inactivate the expression of the antioxidant enzyme GPX4 by inhibiting NRF2 transcription factor, inducing lipid peroxidation and ferroptosis in ARID1A-deficient CRC cells.